Immediate Impact
60 standout
Citing Papers
Towards load-bearing biomedical titanium-based alloys: From essential requirements to future developments
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of X. Wen being referenced
LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC
2021
Biomaterial Strategies to Reduce Implant-Associated Infections
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| X. Wen | 320 | 253 | 32 | 93 | 19 | 448 | |
| Gabriele Inglese | 260 | 180 | 24 | 134 | 28 | 416 | |
| Hai‐Hua Qin | 366 | 246 | 21 | 70 | 21 | 401 | |
| Franck Delvare | 233 | 307 | 3 | 84 | 33 | 430 | |
| Elisa Francini | 273 | 147 | 8 | 155 | 35 | 404 | |
| E. C. Zachmanoglou | 108 | 73 | 47 | 74 | 25 | 435 | |
| Vincenzo Nesi | 208 | 239 | 16 | 347 | 37 | 489 | |
| Guang-Hui Zheng | 266 | 179 | 119 | 41 | 34 | 437 | |
| Joe Coyle | 225 | 221 | 4 | 37 | 10 | 484 | |
| İbrahim Çelik | 55 | 102 | 172 | 40 | 18 | 397 | |
| Ana L. Silvestre | 146 | 98 | 22 | 149 | 27 | 425 |
All Works
Login with ORCID to disown or claim papers
Loading papers...